Endometriosis, a condition that affects one in ten women worldwide, is more than just a medical term. It's a reality for many women and can wreak havoc on their health and quality of life. The journey to diagnosis is often fraught with challenges, delays, and misdiagnoses. Our latest podcast episode seeks to unravel the complexities of endometriosis and the urgent need for better treatments.
We had the privilege of discussing this pervasive women's health issue with Somer Baburek, CEO and co-founder of Hera Biotech. Somer's own struggle with endometriosis was the catalyst for initiating a diagnostic company. She shared valuable insights on the symptoms, challenges faced in diagnosis, and the systemic issues that contribute to women's health outcomes.
One of the most striking facts about endometriosis is the significant diagnostic delay. It takes an average of eight years from symptom onset to diagnosis. This delay is due to a myriad of factors, including the varied locations and appearances of the lesions and the lack of accuracy in current diagnostic tests.
Despite the significant toll it takes on women's health, endometriosis often goes undiagnosed. The impact is not just personal but also systemic, affecting healthcare costs and the broader healthcare system. Stress, for instance, is often examined as a potential contributing factor to endometriosis, highlighting the interconnectedness of our health.
The conversation also highlighted the challenges women face in accessing proper healthcare and treatment. Lack of focus on women's health in the medical field, difficulty in starting a company during a pandemic, and the importance of prioritizing women's health in research and funding were all critical points discussed.
Diagnostic tests for reproductive health, particularly for endometriosis, were another focal point of the discussion. Current tests have limitations, and the potential for blood-based biomarkers is yet to be fully realized. The need for a tissue-based solution was underscored, indicating the necessity for ongoing research and development in endometriosis diagnosis.
In conclusion, the podcast episode painted a comprehensive picture of endometriosis and its implications on women's health. The need for better treatments, improved diagnostic tests, and increased attention to women's health were highlighted as critical steps in addressing this pervasive health issue. As we continue to unravel the complexities of endometriosis, it's clear that every voice matters in this crucial conversation about women's health.